Alkermes, INC.
​Pharmaceutical manufacturing and biopharmaceutical company.
Based in MA
🤖
AI Overview
With $1.4M in lobbying spend across 28 quarterly filings, Alkermes, INC. is a significant lobbying presence.
$1.4M
Total Lobbying Spend
28
Quarterly Filings
1
Lobbying Firms Used
9
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2019 | $50K |
| 2020 | $200K |
| 2021 | $300K |
| 2022 | $250K |
| 2023 | $200K |
| 2024 | $200K |
| 2025 | $240K |
Lobbying Firms
TODD STRATEGY GROUP
What They Lobby For
- Prescription drug pricing.
- Criminal justice bill introduction.
- Prescription drug pricing. C.R.8337: Continuing Appropriations Act, 2021.
- Appropriations related to SAMHSA grant services.
- Prescription drug pricing. H.R.5376 - Build Back Better Act. H.R.3684 - Infrastructure Investment and Jobs Act.
- Prescription drug pricing. H.R.5376 - Build Back Better Act.
- Prescription drug pricing. S.3799 - Prepare for and Respond to Existing Viruses, Emerging New Threats (PREVENT) Pandemics Act. Awareness of outcomes data and the need for training on all medication assisted treatment. H.R.7667/S.4348 - Prescription Drug User Fee Agreement Reauthorization. H.R.5376 - Inflation Reduction Act of 2022.
- Prescription drug pricing. Substance Use Disorder Policy. Implementation of Inflation Reduction Act of 2022.
- Prescription drug pricing, including MDRP Substance Use Disorder Policy. Implementation of Inflation Reduction Act of 2022. Medicaid drug rebate program.
- Prescription drug pricing, including MDRP. Substance Use Disorder Policy. Implementation of Inflation Reduction Act of 2022. Medicaid drug rebate program.
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.